Abstract
In this short chapter, some aspects of immunometabolism of dendritic cells and T cells are briefly sketched. The dichotomous function of dendritic cells is associated with two different metabolic pathways. While resting dendritic cells use fatty acid oxidation to fuel the mitochondrial oxidative phosphorylation pathway, activated immunostimulatory dendritic cells typically switch to aerobic glycolysis, the Otto Warburg metabolism. In contrast to the metabolism of immunostimulatory dendritic cells, an inherently catabolic process, the Krebs cycle and fatty acid oxidation, plays a significant role in the development of tolerogenic dendritic cells.
Like dendritic cells, T cells must adapt to a vast array of environmental DAMPs as part of their regular development, during which they undergo a dramatic metabolic remodelling process as well. Research in this modern area of T cell biology has yielded striking findings on the roles of diverse metabolic pathways and metabolites, which have been found to regulate T cell signalling and influence their differentiation, function, and fate. For example, like immunostimulatory dendritic cells, immune response-promoting activated helper T cell subsets switch their metabolism to aerobic glycolysis, whereas regulatory T cells are less dependent on glycolysis but rely on oxidation phosphorylation pathway. Together, it has now become apparent that the dynamic regulation of metabolic pathways in both cell types drives our immune system to shape distinct T cell responses as required by any given stressful and/or injurious situation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38:633–43. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761313001581
Murray PJ, Rathmell J, Pearce E. SnapShot: immunometabolism. Cell Metab. 2015;22:190–190.e1. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1550413115002818
O’Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213:15–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26694970
O’Neill LAJ, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493:346–55. https://doi.org/10.1038/nature11862.
Jha AK, Huang SC-C, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419–30. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761315000801
Tannahill GM, Curtis AM, Adamik J, EM P-MD, AF MG, G G, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496:238–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23535595
Buck MD, O’Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med. 2015;212:1345–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26261266
Warburg O, Gawehn K, Geissler AW. Metabolism of leukocytes. Z Naturforsch B. 1958;13B:515–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13593654
Pearce EJ, Everts B. Dendritic cell metabolism. Nat Rev Immunol. 2015;15:18–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25534620
McGettrick AF, O’Neill LAJ. How metabolism generates signals during innate immunity and inflammation. J Biol Chem. 2013;288:22893–8. https://doi.org/10.1074/jbc.R113.486464.
Cameron AM, Lawless SJ, Pearce EJ. Metabolism and acetylation in innate immune cell function and fate. Semin Immunol. 2016;28:408–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28340958
Saas P, Varin A, Perruche S, Ceroi A. Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: potential ways to control these functions. Version 2. F1000Res. 2017;6:456. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28580131
Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115:4742–9. https://doi.org/10.1182/blood-2009-10-249540.
Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, et al. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol. 2008;180:4697–705. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18354193
Everts B, Amiel E, Huang SC-C, Smith AM, Chang C-H, Lam WY, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat Immunol. 2014;15:323–32. https://doi.org/10.1038/ni.2833.
Everts B, Amiel E, van der Windt GJW, Freitas TC, Chott R, Yarasheski KE, et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 2012;120:1422–31. https://doi.org/10.1182/blood-2012-03-419747.
Malinarich F, Duan K, Hamid RA, Bijin A, Lin WX, Poidinger M, et al. High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J Immunol. 2015;194:5174–86. https://doi.org/10.4049/jimmunol.1303316.
Svajger U, Obermajer N, Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology. 2010;129:525–35. https://doi.org/10.1111/j.1365-2567.2009.03205.x.
Ferreira GB, Vanherwegen A-S, Eelen G, Gutiérrez ACF, Van Lommel L, Marchal K, et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep. 2015;10:711–25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2211124715000261
Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161:1527–38. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867415005759
Pearce EL, Poffenberger MC, Chang C-H, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342:1242454. https://doi.org/10.1126/science.1242454.
van der Windt GJW, Pearce EL. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev. 2012;249:27–42. https://doi.org/10.1111/j.1600-065X.2012.01150.x.
Chao T, Wang H, Ho P-C. Mitochondrial control and guidance of cellular activities of T cells. Front Immunol. 2017;8:473. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28484465
Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell. 2017;169:570–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28475890
Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186:3299–303. https://doi.org/10.4049/jimmunol.1003613.
Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354:481–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27708054
Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21708926
Araujo L, Khim P, Mkhikian H, Mortales C-L, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28059703
Zeng H, Cohen S, Guy C, Shrestha S, Neale G, Brown SA, et al. mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation. Immunity. 2016;45:540–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27637146
Kopf H, de la Rosa GM, Howard OMZ, Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol. 2007;7:1819–24. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1567576907002809
Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30:832–44. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761309002374
Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, Levine MH, et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282–1293.e7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1550413116306519
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Land, W.G. (2018). Immunometabolism of Dendritic Cells and T Cells. In: Damage-Associated Molecular Patterns in Human Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78655-1_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-78655-1_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78654-4
Online ISBN: 978-3-319-78655-1
eBook Packages: MedicineMedicine (R0)